Event Overview:
Dr. BT Slingsby will give his insights, experiences, and lessons learned as a catalyst for public private partnership (PPP) and external R&D, and provide a view on how this model can be applied to other areas where there is a need of new innovations. Dr. Slingsby is a founding CEO of the Global Health Innovative Technology Fund (GHIT), the world's first PPP fund for global health R&D. GHIT was established in 2013 as an international PPP between Japanese pharmaceutical companies, the Bill and Melinda Gates Foundation, and two Japanese ministries. GHIT’s innovative financing model was conceived and institutionalized by the private sector’s leadership, and GHIT has catalyzed open innovation between Japanese and global entities to create life saving medicines through its investment. Utilizing not only internal but also external R&D resources is becoming an increasingly significant trend in pharmaceutical industry to drive innovations. John W. Carlson III, Chair William Bishop, Yuko Kidoguchi, Takeo Morooka, Toshio Nagase, R. Byron Sigel, Mika Shirai, Vice Chairs ACCJ Healthcare Committee Eiji Sasahara, Chair Seiji Inada, Marc Fuoti, Vice Chairs ACCJ Digital Health Subcommittee William Bishop, Chair Marie Kissel, Yasuhiko Amano, Jun Sekiguchi, Vice Chairs ACCJ Medical Devices and Diagnostics Subcommittee Takeo Morooka, Chair ACCJ Pharmaceuticals Subcommittee Yaju Hiromichi, Chair Satoshi Tanaka, Vice Chair ACCJ Regenerative Medicine and Bioscience Subcommittee NOTE 1: This event is OFF THE RECORD. NOTE 2: If you cancel after the stated deadline, the full meeting fee will be charged to your account. All guests must be accompanied by an ACCJ member. Sorry, no substitutions or walk-ins. NOTE 3: If you are driving to the Tokyo American Club, please inform the ACCJ of the make, model, color and plate of the vehicle, by the registration deadline, as arrangements must be made. A 1,700 yen parking fee will apply. NOTE 4: 500 yen of each participant's attendance fee will be deposited into the Healthcare Committee Fund. Comments are closed.
|
Proudly powered by Weebly
